4//SEC Filing
Recro Pharma, Inc. 4
Accession 0001123292-17-000452
CIK 0001588972operating
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 4:16 PM ET
Size
5.2 KB
Accession
0001123292-17-000452
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2017-02-17$7.59/sh−3,334$25,312→ 766,116 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2016.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.45 to $7.84, inclusive. The reporting person undertakes to provide Recro Pharma, Inc., any security holder of Recro Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2 to this Form 4.
Documents
Issuer
Recro Pharma, Inc.
CIK 0001588972
Entity typeoperating
IncorporatedPA
Related Parties
1- filerCIK 0001588972
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 4:16 PM ET
- Size
- 5.2 KB